Literature DB >> 27439698

c-Fos induction by gut hormones and extracellular ATP in osteoblastic-like cell lines.

Elda Leonor Pacheco-Pantoja1, Jane P Dillon2, Peter J M Wilson2, William D Fraser3, James A Gallagher2.   

Abstract

It is widely accepted that the c-Fos gene has a role in proliferation and differentiation of bone cells. ATP-induced c-Fos activation is relevant to bone homeostasis, because nucleotides that are present in the environment of bone cells can contribute to autocrine/paracrine signalling. Gut hormones have previously been shown to have an effect on bone metabolism. In this study, we used the osteoblastic Saos-2 cell line transfected with a c-Fos-driven reporter stimulated with five gut hormones: glucose inhibitory peptide (GIP), glucagon-like peptide-1 (GLP-1), glucagon-like peptide-2 (GLP-2), ghrelin and obestatin, in the presence or absence of ATP. In addition, TE-85 cells were used to determine the time course of c-Fos transcript induction following stimulation with GLP-1, and GLP-2 with or without ATP, using reverse transcription qPCR. The significant results from the experiments are as follows: higher level of c-Fos induction in presence of GIP, obestatin (p = 0.019 and p = 0.011 respectively), and GIP combined with ATP (p < 0.001) using the luciferase assay; GLP-1 and GLP-2 combined with ATP (p = 0.034 and p = 0.002, respectively) and GLP-2 alone (p < 0.001) using qPCR. In conclusion, three of the gut peptides induced c-Fos, providing a potential mechanism underlying the actions of these hormones in bone which can be directed or enhanced by the presence of ATP.

Entities:  

Keywords:  ATP; GIP; GLP-1; GLP-2; Osteoblasts; c-Fos

Mesh:

Substances:

Year:  2016        PMID: 27439698      PMCID: PMC5124003          DOI: 10.1007/s11302-016-9526-3

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  32 in total

Review 1.  Signal transduction pathways involved in mechanotransduction in bone cells.

Authors:  Astrid Liedert; Daniela Kaspar; Robert Blakytny; Lutz Claes; Anita Ignatius
Journal:  Biochem Biophys Res Commun       Date:  2006-08-14       Impact factor: 3.575

Review 2.  Purinergic signalling and bone remodelling.

Authors:  Isabel R Orriss; Geoffrey Burnstock; Timothy R Arnett
Journal:  Curr Opin Pharmacol       Date:  2010-02-25       Impact factor: 5.547

3.  Essentiality of intron control in the induction of c-fos by glucose and glucoincretin peptides in INS-1 beta-cells.

Authors:  S Susini; G Van Haasteren; S Li; M Prentki; W Schlegel
Journal:  FASEB J       Date:  2000-01       Impact factor: 5.191

4.  Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients.

Authors:  Mathijs C Bunck; Marieke Poelma; E Marelise Eekhoff; Anja Schweizer; Robert J Heine; Giel Nijpels; James E Foley; Michaela Diamant
Journal:  J Diabetes       Date:  2012-06       Impact factor: 4.006

5.  Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects.

Authors:  R J Bollag; Q Zhong; K H Ding; P Phillips; L Zhong; F Qin; J Cranford; A L Mulloy; R Cameron; C M Isales
Journal:  Mol Cell Endocrinol       Date:  2001-05-25       Impact factor: 4.102

6.  Immunohistochemical determination of the site of antidepressant-like effects of glucagon-like peptide-2 in ACTH-treated mice.

Authors:  S Sasaki-Hamada; Y Yuri; M Hoshi; J-I Oka
Journal:  Neuroscience       Date:  2015-03-12       Impact factor: 3.590

7.  Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD.

Authors:  Dennis B Henriksen; Peter Alexandersen; Bolette Hartmann; Charlotte L Adrian; Inger Byrjalsen; Henry G Bone; Jens J Holst; Claus Christiansen
Journal:  Bone       Date:  2009-07-22       Impact factor: 4.398

8.  Synergistic effect of glucagon-like peptide 2 (GLP-2) and of key growth factors on the proliferation of cultured rat astrocytes. Evidence for reciprocal upregulation of the mRNAs for GLP-2 and IGF-I receptors.

Authors:  Esther Velázquez; Enrique Blázquez; Juan Miguel Ruiz-Albusac
Journal:  Mol Neurobiol       Date:  2009-08-13       Impact factor: 5.590

9.  Receptors and effects of gut hormones in three osteoblastic cell lines.

Authors:  Elda L Pacheco-Pantoja; Lakshminarayan R Ranganath; James A Gallagher; Peter J M Wilson; William D Fraser
Journal:  BMC Physiol       Date:  2011-07-29

10.  Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala.

Authors:  J A Parker; K A McCullough; B C T Field; J S Minnion; N M Martin; M A Ghatei; S R Bloom
Journal:  Int J Obes (Lond)       Date:  2013-01-22       Impact factor: 5.095

View more
  7 in total

Review 1.  The Multiple Biological Functions of Dipeptidyl Peptidase-4 in Bone Metabolism.

Authors:  Qiu Yang; Bing Fu; Dan Luo; Haibo Wang; Hongyi Cao; Xiang Chen; Li Tian; Xijie Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-02       Impact factor: 6.055

Review 2.  Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment.

Authors:  Sine Paasch Schiellerup; Kirsa Skov-Jeppesen; Johanne Agerlin Windeløv; Maria Saur Svane; Jens Juul Holst; Bolette Hartmann; Mette Marie Rosenkilde
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-26       Impact factor: 5.555

3.  Purinergic Signaling Mediates PTH and Fluid Flow-Induced Osteoblast Proliferation.

Authors:  Yanghui Xing; Liang Song; Yingying Zhang; Tengyu Zhang; Jian Li; Chunjing Tao
Journal:  Biomed Res Int       Date:  2021-01-27       Impact factor: 3.411

Review 4.  Novel Insights into the Roles and Mechanisms of GLP-1 Receptor Agonists against Aging-Related Diseases.

Authors:  Wei Peng; Rui Zhou; Ze-Fang Sun; Jia-Wei Long; Yong-Qiang Gong
Journal:  Aging Dis       Date:  2022-04-01       Impact factor: 6.745

Review 5.  Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity?

Authors:  C Meurot; C Jacques; C Martin; L Sudre; J Breton; R Rattenbach; K Bismuth; F Berenbaum
Journal:  J Orthop Translat       Date:  2022-02-25       Impact factor: 5.191

Review 6.  The Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms.

Authors:  Chenhe Zhao; Jing Liang; Yinqiu Yang; Mingxiang Yu; Xinhua Qu
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-03       Impact factor: 5.555

7.  A novel P2X2-dependent purinergic mechanism of enteric gliosis in intestinal inflammation.

Authors:  Reiner Schneider; Patrick Leven; Tim Glowka; Ivan Kuzmanov; Mariola Lysson; Bianca Schneiker; Anna Miesen; Younis Baqi; Claudia Spanier; Iveta Grants; Elvio Mazzotta; Egina Villalobos-Hernandez; Jörg C Kalff; Christa E Müller; Fedias L Christofi; Sven Wehner
Journal:  EMBO Mol Med       Date:  2020-12-17       Impact factor: 14.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.